Leukopenia and Hepatotoxicity
Charles D. Ponte, Edward L. Decker
Abstract
Charles D. Ponte, Edward L. Decker
Abstract
A case report of a 72-year-old white female who was treated with a total of 260 mg chlorpromazine and who rapidly developed elevated serum glutamic oxalacetic transaminase, direct and total bilirubin, alkaline phosphatase, and lactic dehydrogenase and whose peripheral white blood cell count dropped to 2,500/mm 3 ' is presented. The bone marrow was found to be hypocellular. Approximately 15 days following discontinuance of the drug, the laboratory values returned toward normal with marked clinical improvement in the patient. The possibility of other drugs causing similar changes in this patient is discussed as are the adverse effects of phenothiazines and methods of monitoring the patient who is receiving phenothiazine therapy.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A case report of a 72-year-old white female who was treated with a total of 260 mg chlorpromazine and who rapidly developed elevated serum glutamic oxalacetic transaminase, direct and total bilirubin, alkaline phosphatase, and lactic dehydrogenase and whose peripheral white blood cell count dropped to 2,500/mm 3 ' is presented. The bone marrow was found to be hypocellular. Approximately 15 days following discontinuance of the drug, the laboratory values returned toward normal with marked clinical improvement in the patient. The possibility of other drugs causing similar changes in this patient is discussed as are the adverse effects of phenothiazines and methods of monitoring the patient who is receiving phenothiazine therapy.
Key concepts: Leukopenia, Transaminase, Alkaline phosphatase, Bilirubin, Medicine, Lactic dehydrogenase, Adverse effect, White blood cell